1094 related articles for article (PubMed ID: 35938889)
1. Smoking cessation for secondary prevention of cardiovascular disease.
Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
[TBL] [Abstract][Full Text] [Related]
2. Smoking cessation for improving mental health.
Taylor GM; Lindson N; Farley A; Leinberger-Jabari A; Sawyer K; Te Water Naudé R; Theodoulou A; King N; Burke C; Aveyard P
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013522. PubMed ID: 33687070
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve smoking cessation rates in primary care.
Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994
[TBL] [Abstract][Full Text] [Related]
6. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
7. Smoking reduction interventions for smoking cessation.
Lindson N; Klemperer E; Hong B; Ordóñez-Mena JM; Aveyard P
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013183. PubMed ID: 31565800
[TBL] [Abstract][Full Text] [Related]
8. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
9. Nicotine receptor partial agonists for smoking cessation.
Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
[TBL] [Abstract][Full Text] [Related]
10. Meditation for the primary and secondary prevention of cardiovascular disease.
Rees K; Takeda A; Court R; Kudrna L; Hartley L; Ernst E
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD013358. PubMed ID: 38358047
[TBL] [Abstract][Full Text] [Related]
11. Patient education in the management of coronary heart disease.
Anderson L; Brown JP; Clark AM; Dalal H; Rossau HK; Bridges C; Taylor RS
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008895. PubMed ID: 28658719
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
Kanie T; Mizuno A; Takaoka Y; Suzuki T; Yoneoka D; Nishikawa Y; Tam WWS; Morze J; Rynkiewicz A; Xin Y; Wu O; Providencia R; Kwong JS
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013650. PubMed ID: 34693515
[TBL] [Abstract][Full Text] [Related]
13. Chelation therapy for atherosclerotic cardiovascular disease.
Villarruz-Sulit MV; Forster R; Dans AL; Tan FN; Sulit DV
Cochrane Database Syst Rev; 2020 May; 5(5):CD002785. PubMed ID: 32367513
[TBL] [Abstract][Full Text] [Related]
14. Fibrates for primary prevention of cardiovascular disease events.
Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
[TBL] [Abstract][Full Text] [Related]
15. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers in patients without heart failure after myocardial infarction.
Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
[TBL] [Abstract][Full Text] [Related]
17. Heated tobacco products for smoking cessation and reducing smoking prevalence.
Tattan-Birch H; Hartmann-Boyce J; Kock L; Simonavicius E; Brose L; Jackson S; Shahab L; Brown J
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013790. PubMed ID: 34988969
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants for smoking cessation.
Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
[TBL] [Abstract][Full Text] [Related]
19. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
20. Mindfulness for smoking cessation.
Jackson S; Brown J; Norris E; Livingstone-Banks J; Hayes E; Lindson N
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013696. PubMed ID: 35420700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
